Promising results with a 14 day variant of the BEACOPP regimen in advanced stage Hodgkin's lymphoma (HL): A pilot-study of the German Hodgkin lymphoma study group (GHSG).

被引：0
|
作者：
Sieber, M [1 ]
Franklin, J [1 ]
Bredenfeld, H [1 ]
Naumann, R [1 ]
Boissevain, F [1 ]
Koch, P [1 ]
Heinz, H [1 ]
Worst, P [1 ]
Soekler, M [1 ]
Rueffer, U [1 ]
Paulus, U [1 ]
Josting, A [1 ]
Wolf, J [1 ]
Tesch, H [1 ]
Engert, A [1 ]
Diehl, V [1 ]
机构：
[1] Univ Cologne, Innere Med Klin 1, Cologne, Germany
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3203
引用
收藏
页码：769A / 769A
页数：1
相关论文
共 50 条
  • [21] Multicentre phase II study of the baseline BEACOPP regimen for patients with advanced-stage Hodgkin's lymphoma
    Niitsu, Nozomi
    Okamoto, Masataka
    Tomita, Naoto
    Aoki, Sadao
    Tamaru, Jun-ichi
    Miura, Ikuo
    Hirano, Masami
    LEUKEMIA & LYMPHOMA, 2006, 47 (09) : 1908 - 1914
  • [22] Prognostic factors in intermediate stage Hodgkin's disease: A retrospective analysis from the German Hodgkin Lymphoma Study Group (GHSG).
    Schiller, P
    Pfistner, B
    Reineke, T
    Paulus, U
    Engert, A
    Wolf, J
    Diehl, V
    BLOOD, 2002, 100 (11) : 772A - 773A
  • [23] Fatigue in long-term survivors of Hodgkin's lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG)
    Rüffer, JU
    Flechtner, H
    Tralls, P
    Josting, A
    Sieber, M
    Lathan, B
    Diehl, V
    EUROPEAN JOURNAL OF CANCER, 2003, 39 (15) : 2179 - 2186
  • [24] Fertility in male patients with Hodgkin's disease after therapy - results from the German Hodgkin Lymphoma Study Group (GHSG).
    Sieniawski, M
    Josting, A
    Breuer, K
    Sven, T
    Diehl, V
    Engert, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 569S - 569S
  • [25] BEACOPP chemotherapy in elderly patients with advanced Hodgkin's disease: Analysis of the randomized trial HD9 for elderly patients of the German Hodgkin lymphoma study group (GHSG).
    Ballova, V
    Franklin, J
    Josting, A
    Wolf, J
    Diehl, V
    Engert, A
    BLOOD, 2003, 102 (11) : 400A - 400A
  • [26] No Reduction of Ovarian Failure with the Use of GnRH-Analogues or Oral Contraceptives in Young Women Treated with Escalated BEACOPP for Advanced-Stage Hodgkin Lymphoma (HL). Final Results of the PROFE Trial, German Hodgkin Study Group (GHSG).
    Behringer, Karolin
    Wildt, Ludwig
    Mueller, Horst
    Ott, Helmut-Werner
    Hofer, Susanne
    Diehl, Volker
    van den Hoonard, Beate
    Engert, Andreas
    Borchmann, Peter
    BLOOD, 2009, 114 (22) : 1429 - 1429
  • [27] Fertility and Gonadal Function After Treatment of Early Unfavorable Hodgkin Lymphoma (HL): An Analysis of the German Hodgkin Study Group (GHSG)
    Behringer, Karolin
    Thielen, Indra
    Mueller, Horst
    Goergen, Helen
    Eibl, Angelika
    Rosenbrock, Johannes
    Halbsguth, Teresa
    Reiners, Katrin S.
    Diehl, Volker
    Engert, Andreas
    Borchmann, Peter
    BLOOD, 2011, 118 (21) : 199 - 199
  • [28] Male fertility in patients with Hodgkin's disease after therapy results from the German Hodgkin Lymphoma Study Group (GHSG).
    Sieniawski, M
    Josting, A
    Breuer, K
    Diehl, V
    Engert, A
    BLOOD, 2003, 102 (11) : 501A - 502A
  • [29] OSTEONECROSIS AS A TREATMENT COMPLICATION IN HODGKIN LYMPHOMA PATIENTS: AN ANALYSIS OF THE GERMAN HODGKIN STUDY GROUP (GHSG)
    Borchmann, S.
    Mueller, H.
    Haverkamp, H.
    Baues, C.
    Markova, J.
    Huettmann, A.
    Glunz, A.
    Fuchs, M.
    Engert, A.
    HAEMATOLOGICA, 2016, 101 : 5 - 6
  • [30] Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG)
    Sven Borchmann
    Horst Müller
    Heinz Haverkamp
    Christian Baues
    Jana Marková
    Andreas Hüttmann
    Axel Glunz
    Michael Fuchs
    Peter Borchmann
    Andreas Engert
    Leukemia, 2019, 33 : 439 - 446
12345